Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration.

The Journal of Biological Chemistry
J R WhiteH M Sarau

Abstract

Interleukin-8 (IL-8) and closely related Glu-Leu-Arg (ELR) containing CXC chemokines, including growth-related oncogene (GRO)alpha, GRObeta, GROgamma, and epithelial cell-derived neutrophil-activating peptide-78 (ENA-78), are potent neutrophil chemotactic and activating peptides, which are proposed to be major mediators of inflammation. IL-8 activates neutrophils by binding to two distinct seven-transmembrane (7-TMR) G-protein coupled receptors CXCR1 (IL-8RA) and CXCR2 (IL-8RB), while GROalpha, GRObeta, GROgamma, and ENA-78 bind to and activate only CXCR2. A chemical lead, which selectively inhibited CXCR2 was discovered by high throughput screening and chemically optimized. SB 225002 (N-(2-hydroxy-4-nitrophenyl)-N'-(2-bromophenyl)urea) is the first reported potent and selective non-peptide inhibitor of a chemokine receptor. It is an antagonist of 125I-IL-8 binding to CXCR2 with an IC50 = 22 nM. SB 225002 showed >150-fold selectivity over CXCR1 and four other 7-TMRs tested. In vitro, SB 225002 potently inhibited human and rabbit neutrophil chemotaxis induced by both IL-8 and GROalpha. In vivo, SB 225002 selectively blocked IL-8-induced neutrophil margination in rabbits. The present findings suggest that CXCR2 is responsible for...Continue Reading

References

Jan 24, 1992·Journal of Medicinal Chemistry·T J LanzaW K Hagmann
Aug 1, 1992·American Journal of Respiratory Cell and Molecular Biology·C M Doerschuk
Jun 11, 1992·Naunyn-Schmiedeberg's Archives of Pharmacology·D P BrooksM Gellai
Oct 1, 1991·The Journal of Clinical Investigation·M S MulliganP A Ward
Feb 15, 1996·Biochemical and Biophysical Research Communications·J M QuanR B Goodman
Sep 1, 1996·The European Respiratory Journal·O A KhairJ L Devalia
Jun 27, 1997·The Journal of Biological Chemistry·S A JonesM Baggiolini

❮ Previous
Next ❯

Citations

Jan 13, 2001·Springer Seminars in Immunopathology·D H McDermott, P M Murphy
Apr 14, 2009·Cellular and Molecular Neurobiology·Peter GálDarina Kluchová
Jun 15, 2011·Investigational New Drugs·Juliana RomaniniMaria M Campos
Dec 4, 2003·Journal of Neuroimmunology·Petra J G ZwijnenburgA Marceline van Furth
Sep 25, 2003·Biochemical Pharmacology·Julie CatusseJean-Luc Paquet
Mar 5, 1999·Immunology Letters·T N WellsC A Power
Jun 17, 2000·Clinics in Dermatology·J M Schröder
Jul 23, 2003·Bioorganic & Medicinal Chemistry Letters·Andrew BaxterJohn Unitt
Apr 16, 2002·The International Journal of Biochemistry & Cell Biology·Anna Barbara HauertVerena Niggli
Sep 7, 2001·Cytokine & Growth Factor Reviews·R Horuk
Oct 18, 2003·Cytokine & Growth Factor Reviews·Peter J Barnes
May 11, 1999·Drug Discovery Today·J Saunders, C M Tarby
Aug 26, 2000·Current Opinion in Chemical Biology·D W Hay
Aug 26, 2000·Current Opinion in Chemical Biology·M A Cascieri, M S Springer
Jul 27, 1999·Current Opinion in Chemical Biology·M K Schwarz, T N Wells
Nov 17, 2001·Current Opinion in Pharmacology·C A Power, A E Proudfoot
Sep 6, 2012·Journal of the American Chemical Society·Caroline de Gracia LuxAdah Almutairi
Aug 31, 2012·Journal of Medicinal Chemistry·James Pease, Richard Horuk
Jul 18, 2002·Nature Reviews. Drug Discovery·Matthias K Schwarz, Timothy N C Wells
Jul 27, 2000·The New England Journal of Medicine·P J Barnes
Jul 31, 2013·The Journal of Experimental Medicine·Laura RaccostaVincenzo Russo
Nov 25, 2000·Journal of Hematotherapy & Stem Cell Research·A WallerL G Czaplewski
Apr 20, 2004·Assay and Drug Development Technologies·Douglas S AuldRob Swanson
Sep 26, 2009·The Journal of Pharmacology and Experimental Therapeutics·Dean Y MaedaJohn A Zebala
Oct 13, 2006·Molecular and Cellular Biology·Nirit Mor-VakninDavid M Markovitz
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·E H OhlsteinJ D Elliott
Jan 25, 2002·Annual Review of Pharmacology and Toxicology·Elias J Fernandez, Elias Lolis
Mar 9, 2005·Respiration; International Review of Thoracic Diseases·Néstor A Molfino
Mar 29, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Dalei WuChristoph Franz Adam Vogel
Nov 11, 1999·American Journal of Respiratory and Critical Care Medicine·P J Barnes

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.